Ticker Symbol: ARTH
Arch Therapeutics Inc
Exchange: OTC MARKETS
Currency:
USD
Asset
Type: Common Stock
CIK:0001537561
Company Profile
arch therapeutics, inc., together with its subsidiaries, operates as a biotechnology company in the united states. the company develops and markets products based on its ac5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. its flagship products include ac5 advanced wound system and ac5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. the company was founded in 2006 and is based in framingham, massachusetts.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
Website: N/A
CEO: N/A
Tags:
- Biotechnology
- Health Technology
- Distribution Services
- Medical Distributors
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 19, 2023 03:00 PM EST
Previous Close: $0.60
Change:
$0.00
(
-0.02%)
Days Range: $0.60 - $0.65
Beta: -
52wk. High: $7.00
52wk. Low: $0.01
Ytd. Change 2207.68%
50 Day Moving Average: $1.19
200 Day Moving Average: $2.19
Shares Outstanding: 4689446
Valuation
Market Cap: 281.4M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A